However, the cardiac phenotype is only present among patients with large NF-1 deletions: a clinical study found that only 6 out of 16 patients with neurofibromatosis had congenital heart disease, and only three of them had cardiac hypertrophy [84]. This evidence concerns the gene NF1 and cardiac hypertrophy.